# TRIAMTERENE AND HYDROCHLOROTHIAZIDE
> **ANDA208358** · Abbreviated New Drug Application (Generic) · Sponsor: CADILA · Approved 2019-02-11
## Drug
- **FDA Application Number:** ANDA208358
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- **Generic name:** TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; TRIAMTERENE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CADILA
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2019-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208358)
---
*MORVS · CC0 1.0*